1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. KT Corporation
  6. News
  7. Summary
    A030200   KR7030200000

KT CORPORATION

(A030200)
  Report
End-of-day quote Korea Stock Exchange  -  2022-06-27
37000.00 KRW   -1.33%
06/21KT, Hanmi Pharmaceuticals Jointly Invest in Digital Therapeutics Firm
MT
06/21UPDATE - KT Corporation and Hanmi Pharmaceutical promote business cooperation with Digital Pharm, a Korean company specializing in digital therapeutics and electroceuticals
AQ
06/21KT Corporation and Hanmi Pharmaceutical Promote Business Cooperation with Digital Pharm
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

KT's Net Profit Jumps 39.5% in March Quarter

05/13/2022 | 03:42am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
KOSPI COMPOSITE INDEX 0.39% 2413.15 Real-time Quote.-20.43%
KT CORPORATION -1.33% 37000 End-of-day quote.20.92%
All news about KT CORPORATION
06/21KT, Hanmi Pharmaceuticals Jointly Invest in Digital Therapeutics Firm
MT
06/21UPDATE - KT Corporation and Hanmi Pharmaceutical promote business cooperation with Digi..
AQ
06/21KT Corporation and Hanmi Pharmaceutical Promote Business Cooperation with Digital Pharm
CI
06/20KT Corporation and Hanmi Pharmaceutical promote business cooperation with Digital Pharm..
AQ
06/19Digital Pharm announced that it has received funding from KT Corporation, Hanmi Pharm. ..
CI
06/15Kymera Therapeutics Starts Dosing Patients With Solid Tumors, Lymphomas in 2 Phase 1 Tr..
MT
06/14Overseas Investors' Interest Shifts to KT, LG Uplus from SK Telecom
MT
06/13Rajesh Exports setting up India's first display plant with $3 billion investment
RE
06/01Kymera Therapeutics Receives FDA Orphan Drug Designation for Peripheral T-Cell Lymphoma..
MT
06/01Kymera Therapeutics Gets Orphan Drug Designation for KT-333 Lymphoma Treatment
DJ
More news
Analyst Recommendations on KT CORPORATION
More recommendations
Financials
Sales 2022 25 713 B 19,9 B 19,9 B
Net income 2022 1 222 B 0,95 B 0,95 B
Net Debt 2022 4 621 B 3,58 B 3,58 B
P/E ratio 2022 7,54x
Yield 2022 5,81%
Capitalization 8 725 B 6 761 M 6 761 M
EV / Sales 2022 0,52x
EV / Sales 2023 0,47x
Nbr of Employees 20 705
Free-Float 89,7%
Chart KT CORPORATION
Duration : Period :
KT Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends KT CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 22
Last Close Price 37 000,00 KRW
Average target price 44 500,00 KRW
Spread / Average Target 20,3%
EPS Revisions
Managers and Directors
Hyun-Mo Gu Chief Executive Officer & Director
Young-Jin Kim Managing Director & Head-Finance
Soo-Jung Shin VP & Head-Information Technology Planning
Hee-Yeol Yu Independent Director
Kang-Chul Lee Independent Director
Sector and Competitors
1st jan.Capi. (M$)
KT CORPORATION20.92%6 815
VERIZON COMMUNICATIONS-1.92%214 014
CHINA MOBILE LIMITED4.38%132 817
NIPPON TELEGRAPH AND TELEPHONE CORPORATION23.43%103 515
DEUTSCHE TELEKOM AG15.83%99 019
CHARTER COMMUNICATIONS, INC.-28.97%74 436